#Biopharmaceuticals #LiverDisease #FDAApproval

www.benzinga.com

Altimmune Receives FDA Breakthrough Therapy Designation for Pemvidutide in MASH - Altimmune (NASDAQ:ALT)

GAITHERSBURG, Md.